Kari Grønås

Director/Board Member at SPAGO NANOMEDICAL AB

61 year

Health Technology

Commercial Services

Consumer Services

Profile

Kari Grønås is currently Chairman at Norwegian Cancer Society and Lungekreftforeningen.
Ms. Grønås is Director at Oncoinvent ASA since 2024, Independent Director at Spago Nanomedical AB since 2018, Managing Director & Director at K & K AS since 2012, and Director at Arxx Therapeutics AS.
Former roles include Chairman at Norwegian Pharmaceutical Society, Director at Oncopeptides AB, Lytix Biopharma AS, SoftOx.
Solutions AS, Ultimovacs ASA, and Oncoinvent ASA (Old).
Ms. Grønås was Independent Non-Executive Director at Oncoinvent ASA from 2016 to 2019 and Senior Vice President-Operations at Algeta ASA. Education includes a graduate degree from the University of Oslo.

Kari Grønås active positions

Companies	Position	Start
SPAGO NANOMEDICAL AB	Director/Board Member	01/01/2018
ONCOINVENT ASA	Director/Board Member	01/01/2024
K & K AS K & K AS Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services	Chief Executive Officer	21/05/2012
Norwegian Cancer Society	Chairman	-
Arxx Therapeutics AS Arxx Therapeutics AS BiotechnologyHealth Technology Develops therapeutics for fibrotic diseases	Director/Board Member	-

All active positions of Kari Grønås

Former positions of Kari Grønås

Companies	Position	End
ONCOINVENT ASA	Director/Board Member	13/03/2019
Oncoinvent AS Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment	Director/Board Member	-
ONCOPEPTIDES AB	Director/Board Member	-
Ultimovacs ASA Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine	Director/Board Member	-
░░░░░░ ░░░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Kari Grønås's experience

Training of Kari Grønås

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kari Grønås's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Oncopeptides AB Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment	Health Technology
University of Oslo University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Algeta ASA Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer	Health Technology
Lytix Biopharma AS Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies	Health Technology
BerGenBio ASA BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers	Health Technology
Spago Nanomedical AB Spago Nanomedical AB BiotechnologyHealth Technology Acts as a biotechnology company	Health Technology
Ultimovacs ASA Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine	Health Technology
Oncoinvent AS Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment	Health Technology
Norwegian Pharmaceutical Society
SoftOx Solutions AS SoftOx Solutions AS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures non-toxic & antiseptic medicines	Commercial Services
K & K AS K & K AS Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services	Commercial Services
Norwegian Cancer Society
Arxx Therapeutics AS Arxx Therapeutics AS BiotechnologyHealth Technology Develops therapeutics for fibrotic diseases	Health Technology